The Immune System in Cancer Prevention, Development and Therapy

被引:106
作者
Candeias, Serge M. [1 ,2 ,3 ]
Gaipl, Udo S. [4 ]
机构
[1] CEA, iRTSV LCBM, F-38000 Grenoble, France
[2] CNRS, IRTSV LCBM, F-38000 Grenoble, France
[3] Univ Grenoble Alpes, iRTSV LCBM, F-38000 Grenoble, France
[4] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Radiat Oncol, Nurnberg, Germany
关键词
Immune system; immunotherapy; inflammation; tumor prevention; tumor promotion; HEAT-SHOCK PROTEINS; TUMOR SURVEILLANCE; INTERFERON-GAMMA; DENDRITIC CELLS; DANGER SIGNALS; MYELOID CELLS; IFN-GAMMA; GLIOBLASTOMA; HYPERTHERMIA; PERFORIN;
D O I
10.2174/1871520615666150824153523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The immune system plays a pivotal role in the maintenance of the integrity of an organism. Besides the protection against pathogens, it is strongly involved in cancer prevention, development and defense. This review focuses on how the immune system protects against infections and trauma and on its role in cancer development and disease. Focus is set on the interactions of the innate and adaptive immune system and tumors. The role of IFN-gamma as a pleiotropic cytokine that plays a very important role at the interface of innate and adaptive immune systems in tumor development and induction of anti-tumor immune responses is outlined. Further, immune cells as prognostic and predictive markers of cancer will be discussed. Data are provided that even the brain as immune privileged organ is subjected to immune surveillance and consequently also brain tumors. Immune therapeutic approaches for glioblastoma multiforme, the most frequent and malignant brain tumor, based on vaccination with dendritic cells are outlined and application of hyperthermia in form of magnetic nanoparticles is discussed. We conclude that the immune system and developing tumors are intimately intertwined. Anti-tumor immune responses can be prominently boosted by multimodal therapies aiming on the one hand to induce immunogenic tumor cell death forms and on the other hand to actively counteract the immune suppressive microenvironment based on the tumor itself.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 88 条
  • [1] Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
    Ardon, Hilko
    Van Gool, Stefaan W.
    Verschuere, Tina
    Maes, Wim
    Fieuws, Steffen
    Sciot, Raf
    Wilms, Guido
    Demaerel, Philippe
    Goffin, Jan
    Van Calenbergh, Frank
    Menten, Johan
    Clement, Paul
    Debiec-Rychter, Maria
    De Vleeschouwer, Steven
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) : 2033 - 2044
  • [2] High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993
    Atkins, MB
    Lotze, MT
    Dutcher, JP
    Fisher, RI
    Weiss, G
    Margolin, K
    Abrams, J
    Sznol, M
    Parkinson, D
    Hawkins, M
    Paradise, C
    Kunkel, L
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2105 - 2116
  • [3] Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
    Balachandran, Vinod P.
    Cavnar, Michael J.
    Zeng, Shan
    Bamboat, Zubin M.
    Ocuin, Lee M.
    Obaid, Hebroon
    Sorenson, Eric C.
    Popow, Rachel
    Ariyan, Charlotte
    Rossi, Ferdinand
    Besmer, Peter
    Guo, Tianhua
    Antonescu, Cristina R.
    Taguchi, Takahiro
    Yuan, Jianda
    Wolchok, Jedd D.
    Allison, James P.
    DeMatteo, Ronald P.
    [J]. NATURE MEDICINE, 2011, 17 (09) : 1094 - U99
  • [4] Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
    Bernard, Jamie J.
    Cowing-Zitron, Christopher
    Nakatsuji, Teruaki
    Muehleisen, Beda
    Muto, Jun
    Borkowski, Andrew W.
    Martinez, Laisel
    Greidinger, Eric L.
    Yu, Benjamin D.
    Gallo, Richard L.
    [J]. NATURE MEDICINE, 2012, 18 (08) : 1286 - +
  • [5] L-arginine metabolism in myeloid cells controls T-lymphocyte functions
    Bronte, V
    Serafini, P
    Mazzoni, A
    Segal, DM
    Zanovello, P
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (06) : 302 - 306
  • [6] Sterile inflammation: sensing and reacting to damage
    Chen, Grace Y.
    Nunez, Gabriel
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (12) : 826 - 837
  • [7] HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
    Curtin, James F.
    Liu, Naiyou
    Candolfi, Marianela
    Xiong, Weidong
    Assi, Hikmat
    Yagiz, Kader
    Edwards, Matthew R.
    Michelsen, Kathrin S.
    Kroeger, Kurt M.
    Liu, Chunyan
    Muhammad, A. K. M. Ghulam
    Clark, Mary C.
    Arditi, Moshe
    Comin-Anduix, Begonya
    Ribas, Antoni
    Lowenstein, Pedro R.
    Castro, Maria G.
    [J]. PLOS MEDICINE, 2009, 6 (01) : 83 - 104
  • [8] Diamond RA, 1997, J IMMUNOL, V158, P4052
  • [9] ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS
    DIGHE, AS
    RICHARDS, E
    OLD, LJ
    SCHREIBER, RD
    [J]. IMMUNITY, 1994, 1 (06) : 447 - 456
  • [10] DING AH, 1988, J IMMUNOL, V141, P2407